Categories
- Anatomy
- Biochemistry
- BioEngineering
- BioInformatics
- Biology
- Biotechnology
- Cardiology
- Cell Medicine
- Cell Therapy
- Chemistry
- DNA
- Embryology
- Future Medicine
- Gene Medicine
- Gene Therapy
- Genetic Engineering
- Genetic Therapy
- Genetics
- Germ Line Engineering
- Human Genetics
- IVF Treatment
- Longevity Medicine
- Medical News
- Medical School
- Medical Technology
- Medicine
- Molecular Genetics
- Molecular Medicine
- Nano Medicine
- Nanotechnology
- Pet Stem Cell Therapy
- Stem Cell Therapy
Archives
Popular Search Keywords
Tag Archives: the-development
Anatomy of an Indie Hit: A Conversation with Ben Lewin – Video
Anatomy of an Indie Hit: A Conversation with Ben Lewin Co-production between BAFTA Los Angeles and the SAG Foundation. A discussion of Ben Lewin's extraordinary life and career and examination on the development,… Continue reading
Posted in Anatomy
Tagged angeles, career-and, conversation, development, foundation, generated, indie, lewin, life-and, sag, the-development, xamination-on-the
Comments Off
GENERAL EMBRYOLOGY FOR DENTAL SUDENTS COMPILED AND MODIFIED – Video
GENERAL EMBRYOLOGY FOR DENTAL SUDENTS COMPILED AND MODIFIED Diagrammatic representation of the development of the head and neck region for undergraduate students, particularly Oral Biology. The module is available thr… By: Yssa Lesmoras Continue reading
Posted in Embryology
Tagged and-, and-neck, available-thr-, Biology, development, for-, generated, head, lesmoras, region-for, the-development, the-head
Comments Off
Research and Markets: Personalized Medicine – Scientific and Commercial Aspects – Updated 2013 Report
DUBLIN–(BUSINESS WIRE)– Research and Markets (http://www.researchandmarkets.com/research/c247cv/personalized) has announced the addition of Jain PharmaBiotech’s new report “Personalized Medicine – Scientific and Commercial Aspects” to their offering. The aim of personalized medicine or individualized treatment is to match the right drug to the right patient and, in some cases, even to design the appropriate treatment for a patient according to his/her genotype. Continue reading
Posted in Medicine
Tagged a-system-are, development, family, generated, match-the-right, pharmaceutical, report, study, the-development
Comments Off
Response Genetics to Present at the 2013 UBS Global Healthcare Conference
LOS ANGELES, May 8, 2013 (GLOBE NEWSWIRE) — Response Genetics, Inc. (RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient’s response to cancer therapy, announced today that Thomas A Continue reading
Posted in Genetics
Tagged a-live-webcast, chairman, execute-on-its, Genetics, pharmaceutical, press, private, response, response-genetics, statements, the-development
Comments Off
Narrower-than-Expected Loss at Seattle Genetics
Seattle Genetics, Inc. (SGEN) reported first quarter 2013 net loss per share of 14 cents, narrower than the Zacks Consensus Estimate of a loss of 19 cents, but wider than the year-ago loss of 11 cents per share Continue reading
Posted in Genetics
Tagged adcetris, first, frontline-study, pipeline-update, roche-holding, seattle, seattle-genetics, study, the-development, year, zacks
Comments Off
Response Genetics, Inc. to Release First Quarter 2013 Financial Results and Host Conference Call on May 14, 2013
LOS ANGELES, May 6, 2013 (GLOBE NEWSWIRE) — Response Genetics, Inc. Continue reading
Posted in Genetics
Tagged a-press-release-, call, conference-, focused-on-the, generated, Genetics, live, medical, pharmaceutical, press-release, research, response, securities, statements, the-development
Comments Off
Celebrate DNA Day with Life Technologies – Video
Celebrate DNA Day with Life Technologies Learn more at http://www.lifetechnologies.com/dna60 Celebrate DNA Day. This is a fun video about the findings that paved the way for the development of a mol… Continue reading
Posted in DNA
Tagged a-fun-video, celebrate, development, DNA, findings, fun-video, generated, more-at-http, paved-the, paved-the-way, technologies, the-development, way-for
Comments Off
ANGANY Genetics Announces the Launch of Its New Production Unit and Gears up for Supply of Its First Allergens for the …
VAL-DE-REUIL, France–(BUSINESS WIRE)– ANGANY Genetics, a biotechnology company specialising in the development and production of recombinant allergens for the diagnosis and treatment of allergies, plans to start its new production unit at the PharmaParc II activities park in Val-de-Reuil (Eure) in May. Continue reading
Posted in Genetics
Tagged and-treatment, development, diagnosis, europe, european, normandy, president, requirements, scientific, spring, the-development, vronique-gomord
Comments Off
Financial Assessment of the Global Pharmaceutical and Biotechnology Industry
NEW YORK, March 19, 2013 /PRNewswire/ — Reportlinker.com announces that a new market research report is available in its catalogue: Financial Assessment of the Global Pharmaceutical and Biotechnology Industry http://www.reportlinker.com/p01120885/Financial-Assessment-of-the-Global-Pharmaceutical-and-Biotechnology-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pharmaceutical Financial Management is the Key Strategy for Sustainability This financial assessment study analyzes the financial ratios of public companies across the globe in the pharmaceutical and biotechnology industry. The research objectives are to rank companies based on their financial and risk management while also identifying key trends that can impact the performance of industry participants over the next year. Continue reading
Posted in Biotechnology
Tagged a-new-market, analysis, based-on-their, Biotechnology, generated, globe, smaller-margins, the-development, turnover-ratios, york
Comments Off
BG Medicine to Announce Fourth Quarter and Year-End 2012 Financial Results and Host Conference Call on Wednesday …
WALTHAM, Mass., March 6, 2013 (GLOBE NEWSWIRE) — BG Medicine, Inc. (BGMD) today announced that the company will host a conference call and webcast on Wednesday, March 13 at 8:30 a.m. Eastern Time to discuss its fourth quarter and year-end 2012 financial results Continue reading
Posted in Medicine
Tagged access-the-live, call-on-march, conference-, europe, focused-on-the, improve-patient, investor, live-conference, Medicine, medicine-inc-, the-development, today-announced, united-states
Comments Off
Dr.Sherif- Embryology 8 " the development of tongue
Dr.Sherif- Embryology 8 ” the development of tongue thyroid gland ” Sunday 3/3/2013 the development of tongue thyroid gland By: forsan2ndyear Continue reading
Posted in Embryology
Tagged 2013-the, 2013-the-development, development, Embryology, generated, sherif-embryology, the-development, tongue-thyroid
Comments Off
BG Medicine, Inc. Announces Publication of Two Studies Supporting Repeat Galectin-3 Testing in Heart Failure Patients
WALTHAM, Mass., Feb. 27, 2013 (GLOBE NEWSWIRE) — BG Medicine, Inc. (BGMD), a diagnostics company focused on the development and commercialization of novel cardiovascular tests, announced today the publication of two studies demonstrating the clinical utility of repeated galectin-3 testing as a tool in the assessment of patients with heart failure. Continue reading
Posted in Medicine
Tagged a-routine-part, clinical, galectin, generated, heart, increased, management, Medicine, patients-with, president, risk, the-development
Comments Off
BG Medicine, Inc. to Present at Cowen and Company 33rd Annual Health Care Conference
WALTHAM, Mass., Feb. 27, 2013 (GLOBE NEWSWIRE) — BG Medicine, Inc. (BGMD) ), a company focused on the development and commercialization of novel cardiovascular diagnostics, announced today that Eric Bouvier, BG Medicine’s President and CEO, will be presenting at the Cowen and Company 33rd Annual Health Care Conference on March 4, 2013, at the Boston Marriott Copley Place, beginning at 2:10 PM Eastern Time (ET) Continue reading
Posted in Medicine
Tagged announced-today, annual-health, audio, boston, boston-marriott, cardioscore, copley-place, development, eastern-time-, europe, improve-patient, live, the-development, united
Comments Off
Jennerex Announces Nature Medicine Publication Highlighting Randomized Overall Survival Benefit of Lead Product …
SAN FRANCISCO, CA–(Marketwire – Feb 10, 2013) – Jennerex, Inc., a private, clinical-stage biotherapeutics company focused on the development and commercialization of best-in-class targeted oncolytic immunotherapies for solid tumors, today announced the publication of research demonstrating the ability of its lead product-candidate, Pexa-Vec (JX-594) to significantly prolong survival in advanced hepatocellular carcinoma (HCC) patients in a randomized dose comparison clinical trial. This research, published in Volume 19, Issue 2 of Nature Medicine, showed a statistically significant dose-dependent overall survival benefit with 14.1 months median overall survival for the high-dose group compared to 6.7 months for the low-dose group (p-value = 0.02) Continue reading
Posted in Medicine
Tagged development, europe, generated, highly-targeted, institut-mrieux, nature-, phase, san, south-korea, the-development, unique
Comments Off
Medical Embryology – Development of the aortic arches 600 SUBSCRIBERS! – Video
Medical Embryology – Development of the aortic arches 600 SUBSCRIBERS! Thanks to everyone who has watched and subscribed to these videos. Continue reading
Posted in Embryology
Tagged a-special-treat, aortic, best-effort, development, Embryology, generated, gross, gross-anatomy, little-arteries, mature, special-treat, the-aortic, the-development, the-morphology, these-videos
Comments Off
BG Medicine, Inc. Announces Closing of Public Offering and Exercise of Over-Allotment Option
WALTHAM, Mass., Jan. 30, 2013 (GLOBE NEWSWIRE) — BG Medicine, Inc. (BGMD), a diagnostics company focused on the development and commercialization of novel cardiovascular tests, today announced the closing of its previously announced public offering of 6,000,000 shares of its common stock, as well as 900,000 additional shares of its common stock pursuant to the full exercise of the over-allotment option granted to the underwriter. Continue reading
Posted in Medicine
Tagged cardioscore, communication, date, from-the-public, markets, Medicine, medicine-inc-, press, securities, the-development, underwriter, united-states
Comments Off
Embryology of the Head and Neck – Chapter 3: Congenital Defects – Video
Embryology of the Head and Neck – Chapter 3: Congenital Defects Diagrammatic representation of the development of the head and neck region for undergraduate students, particularly Oral Biology. The module is available through the African Health OER Network at: www.oerafrica.org Any medical information in this material is intended to inform and educate and is not a tool for self-diagnosis or a replacement for medical evaluation, advice, diagnosis or treatment by a healthcare professional. Continue reading
Posted in Embryology
Tagged a-tool-for, generated, head, licensed-under, material, medical, medical-content, the-development, western-cape, your-medical
Comments Off
Potential stem cell therapy for Duchenne’s
By Sally Robertson, medwireNews Reporter Researchers have found that injecting aorta-derived stem cells into the hearts of dystrophin-deficient mice prevents the onset of dilated cardiomyopathy (DCM), raising hopes of a potential new treatment approach to prevent or reverse the condition in human Duchenne muscular dystrophy. “This is the first report of stem cell therapy yielding functional benefit in the dystrophin-deficient heart,” say Suzanne Berry (University of Illinois, Urbana, USA) and team. As reported in Stem Cells Translational Medicine, injection of wild-type aorta-derived mesoangioblasts (ADMs) containing a functional copy of the dystrophin gene, significantly improved heart function compared with deficient mice injected with saline (controls). Continue reading
Posted in Stem Cell Therapy
Tagged a-potential-new, adms, control, first, generated, hearts, neurofilament, proliferation, sally-robertson, suzanne-berry, team, the-development, usa, wall-or-septum
Comments Off